NVL-330

NVL-330 · Nuvalent Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NVL-330, covering 2026-02-25 to 2026-02-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1) [Phase 1]